COMP <GO>
CPT vs BAC // FORWARD P/E MULTIPLE
Camden Property Trust (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CPT 11
— BAC 4
▲ FORWARD P/E MULTIPLE LEADER: BAC
LAST: $100.69 (-0.25%) • MKT CAP: $10.15B
forward-pe
22.2x
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
forward-pe
10.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPT VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPT | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 41.00% | -71.00 | BAC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.90% | 2.50% | +3.40 | CPT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 30.2x | -4.50 | CPT | /valuation <GO> |
| Free Cash Flow Yield | 8.14% | 2.10% | +6.04 | CPT | /fcf-yield <GO> |
| Operating Margin | 75.00% | 32.90% | +42.10 | CPT | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 27.00% | +41.00 | CPT | /net-margins <GO> |
| Revenue Growth (YoY) | 81.70% | 6.80% | +74.90 | CPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.54% | 0.00% | +4.54 | CPT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.01 | 0.45 | +1.56 | CPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.60% | +0.80 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 27.7 | +24.84 | CPT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.90 | +0.25 | CPT | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 22.2x | 10.9x | +11.30 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.15B | $357.61B | -$347.46B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPT REV | BAC REV | CPT GROSS % | BAC GROSS % | CPT FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.0M | $113.10B | -4270.4% | 44.0% | $826.0M | $7.52B |
| FY 2024 | $7.1M | $105.86B | -7729.7% | 44.0% | $774.6M | -$13.57B |
| FY 2023 | $3.5M | $102.77B | 44.0% | 44.0% | $794.8M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPT // BETA 1.15
BAC // BETA 0.90